Berlin - Delayed Quote EUR
OPKO Health Inc (XCY.BE)
1.1622
-0.0744
(-6.02%)
As of 8:08:28 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
713,142
713,142
863,495
1,004,196
1,774,718
Cost of Revenue
494,632
494,632
545,368
715,977
1,193,194
Gross Profit
218,510
218,510
318,127
288,219
581,524
Operating Expense
492,068
492,068
476,184
534,343
595,985
Operating Income
-273,558
-273,558
-158,057
-246,124
-14,461
Net Non Operating Interest Income Expense
-39,039
-39,039
-9,523
-10,075
-18,852
Other Income Expense
302,235
302,235
-16,739
-135,322
19,288
Pretax Income
-10,362
-10,362
-184,319
-391,521
-14,025
Tax Provision
42,844
42,844
4,437
-63,499
15,489
Earnings from Equity Interest Net of Tax
-18
-18
-107
-383
-629
Net Income Common Stockholders
-53,224
-53,224
-188,863
-328,405
-30,143
Diluted NI Available to Com Stockholders
-53,224
-53,224
-188,863
-328,405
-30,143
Basic EPS
-0.19
-0.08
-0.25
-0.46
-0.05
Diluted EPS
-0.19
-0.08
-0.25
-0.46
-0.05
Basic Average Shares
712,735.3540
694,019.5350
751,716.9150
719,060.9420
648,077.7160
Diluted Average Shares
712,735.3540
694,019.5350
751,716.9150
719,060.9420
648,077.7160
Total Operating Income as Reported
-152,065
-152,065
-157,021
-226,253
18,750
Total Expenses
986,700
986,700
1,021,552
1,250,320
1,789,179
Net Income from Continuing & Discontinued Operation
-53,224
-53,224
-188,863
-328,405
-30,143
Normalized Income
-128,536.2800
-128,536.2800
-189,064.4500
-345,600.7600
-55,004.6100
Interest Income
8,426
8,426
3,983
1,981
28
Interest Expense
47,465
47,465
13,506
12,056
18,880
Net Interest Income
-39,039
-39,039
-9,523
-10,075
-18,852
EBIT
37,103
37,103
-170,813
-379,465
4,855
EBITDA
135,279
135,279
-65,516
-270,810
83,571
Reconciled Cost of Revenue
479,090
479,090
526,103
695,106
1,164,756
Reconciled Depreciation
98,176
98,176
105,297
108,655
78,716
Net Income from Continuing Operation Net Minority Interest
-53,224
-53,224
-188,863
-328,405
-30,143
Total Unusual Items Excluding Goodwill
95,332
95,332
255
20,520
34,057
Total Unusual Items
95,332
95,332
255
20,520
34,057
Normalized EBITDA
39,947
39,947
-65,771
-291,330
49,514
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0003
Tax Effect of Unusual Items
20,019.7200
20,019.7200
53.5500
3,324.2400
9,195.3900
12/31/2021 - 6/13/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade